Regulation of adenovirus-mediated elafin transgene expression by bacterial lipopolysaccharide

Human Gene Therapy

Volumn 12, Issue 11, 2001, Pages 1395-1406

  Simpson, A John ^a   Cunningham, Gráinne A ^a   Porteous, David J ^b   Haslett, Haslett ^a   Sallenave, Jean Michel ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; ELAFIN; RECOMBINANT DNA; SODIUM CHLORIDE;

ADENOVIRUS; AIRWAY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; EPITHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE MIGRATION; LUNG ALVEOLUS EPITHELIUM; MOUSE; NEUTROPHIL; NONHUMAN; PNEUMONIA; PROMOTER REGION; PROTEIN SECRETION; RODENT; TRANSGENE; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; ANTI-INFECTIVE AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOMEGALOVIRUS; FEMALE; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LAC OPERON; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED C57BL; NEUTROPHIL INFILTRATION; NEUTROPHILS; PROMOTER REGIONS (GENETICS); PROTEINASE INHIBITORY PROTEINS, SECRETORY; PROTEINS; RNA, MESSENGER; TRANSFECTION; TRANSGENES; TUMOR CELLS, CULTURED; UP-REGULATION;

ADENOVIRIDAE; ANIMALIA; BACTERIA (MICROORGANISMS); CYTOMEGALOVIRUS; MOUSE CYTOMEGALOVIRUS 1; MURINAE; RODENTIA;

EID: 0034821325     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303401750298553     Document Type: Article

References (63)

1. Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors
2. Effects of alpha 1-proteinase inhibitor on chemotaxis and chemokinesis of polymorphonuclear leukocytes: Its possible role in regulating polymorphonuclear leukocyte recruitment in human subjects
3. Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide
4. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis
5. Compartmentalized interleukin-8 and elastase release within the human lung in unilateral pneumonia
6. Human leukocyte elastase is an endogenous ligand for the integrin CR3 (CD11b/CD18, Mac-1, αMβ2) and modulates polymorphonuclear leukocyte adhesion
7. Intrapulmonary TNF gene therapy reverses sepsis-induced suppression of lung antibacterial host defense
8. Role of neutrophil depletion and elastase inhibition in modifying skeletal muscle reperfusion injury
9. Acute inflammation and microthrombosis induced by endotoxin, interleukin-1, and tumor necrosis factor and their implication in Gram-negative sepsis
10. Granulocyte activation by endotoxin. 1. Correlation between adherence and other granulocyte functions, and role of endotoxin structure on biologic activity
11. Gene therapy for oxidant injury-related diseases: Adenovirus-mediated transfer of superoxide dismutase and catalase cDNAs protects against hyperoxia but not against ischemia-reperfusion lung injury
12. A long and complex enhancer activates transcription of the gene coding for the highly abundant immediate early mRNA in murine cytomegalovirus
13. Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema
14. Regulatory effects of endogenous protease inhibitors in acute inflammatory lung injury
15. Transcriptional activation by tetracycline in mammalian cells
16. Gene transfer and expression protocols
17. Interleukin-12 gene therapy protects mice in lethal Klebsiella pneumonia
18. Efficient adenovirus-mediated gene transfer into human blood monocyte-derived macrophages
19. Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide
20. Antibacterial activity of antileukoprotease
21. Granulocyte recruitment to airways exposed to endotoxin aerosols
22. Secretory leukocyte protease inhibitor: A macrophage product induced by and antagonistic to bacterial lipopolysaccharide
23. Modification of the genetic program of human alveolar macrophages by adenovirus vectorsin vitro is feasible but inefficient, limited in part by the low level of expression of the Coxsackie/adenovirus receptor
24. Interferon-gamma and CD8+ T cells restore host defenses against Pneumocystis carinii in mice depleted of CD4+ T cells
25. Human neutrophil elastase abolishes interleukin-8 chemotactic activity
26. Proteolysis of monocyte CD14 by human leukocyte elastase inhibits lipopolysaccharide-mediated cell activation
27. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells
28. Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: Involvement of NFκB
29. Migration of neutrophils across human pulmonary endothelial cells is not blocked by matrix metalloproteinases or serine protease inhibitors
30. Bacterial DNA is implicated in the inflammatory response to delivery of DNA/DOTAP to mouse lungs
31. SKALP/elafin: An elastase inhibitor from cultured human keratinocytes. Purification, cDNA sequence, and evidence for transglutaminase cross-linking
32. Endotoxin and disease mechanisms
33. In vivo suppression of immune complex-induced alveolitis by secretory leukoproteinase inhibitor and tissue inhibitor of metalloproteinases 2
34. Ecdysone-inducible gene expression in mammalian cells and transgenic mice
35. Cell surface-bound elastase and cathepsin G on human neutrophils: A novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases
36. Binding of polycationic antibiotics and polyamines to lipopolysaccharides of Pseudomonas aeruginosa
37. Human neutrophil elastase regulates the expression of elafin (elastase-specific inhibitor) in type II alveolar epithelial cells
38. Inhibition of lipopolysaccharide-induced pulmonary emphysema by intratracheally instilled recombinant secretory leukocyte proteinase inhibitor
39. The role of secretory leukocyte proteinase inhibitor and elafin (elastase-specific inhibitor/skin-derived antileukoprotease) as alarm antiproteinases in inflammatory lung disease
40. Purification and characterization of elastase-specific inhibitor
41. Characterization and gene sequence of the precursor of elafin, an elastase-specific inhibitor in bronchial secretions
42. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes
43. Adenovirus-mediated expression of an elastase-specific inhibitor (elafin): A comparison of different promoters
44. The trappin family: Proteins defined by an N-terminal transglutaminase substrate domain and a C-terminal four-disulphide core
45. Adenovirus-mediated gene transfer into monocyte-derived macrophages of patients with X-linked chronic granulomatous disease: Ex vivo correction of deficient respiratory burst
46. Elafin (elastase-specific inhibitor) has anti-microbial activity against Gram-positive and Gram-negative respiratory pathogens
47. Elastolytic activity of sputum and its relation to purulence and to lung function in patients with bronchiectasis
48. Effect of alpha-1-proteinase inhibitor on neutrophil chemotaxis
49. Inhibition of elastase improves myocardial function after repetitive ischaemia and myocardial infarction in the rat heart
50. Intratracheal gene delivery with adenoviral vector induces elevated systemic IgG and mucosal IgA antibodies to adenovirus and β-galactosidase
51. Intratracheal aerosolization of endotoxin (LPS) in the rat: A comprehensive animal model to study adult (acute) respiratory distress syndrome
52. Regulation of SLPI and elafin release from bronchial epithelial cells by neutrophil defensins
53. Inflammation-induced recombinant protein expression in vivo using promoters from acute-phase protein genes
54. Antibacterial activity of human neutrophil defensins in experimental infections is accompanied by increased leukocyte accumulation
55. Elafin: An elastase-specific inhibitor in human skin. Purification, characterization, and complete amino acid sequence
56. Elafin is a potent inhibitor of proteinase 3
57. Expression of secretory leukocyte protease inhibitor (SLPI) and elafin by primary human alveolar type II pneumocytes (TII) in vitro
58. Role of alveolar macrophages in rapid elimination of adenovirus vectors administered to the epithelial surface of the respiratory tract
59. Selective expansion of alveolar macrophages in vivo by adenovirus-mediated transfer of the murine granulocyte-macrophage colony-stimulating factor cDNA
60. Fibronectin and serum amyloid P component stimulate C3b- and C3bi-mediated phagocytosis in cultured human monocytes
61. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy
62. Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases
63. Internalization of adenovirus by alveolar macrophages initiates early proinflammatory signaling during acute respiratory tract infections